Drug Topics' Hospital Pharmacist Report


Drug Topics E-News: Having trouble viewing this e-mail? Click here.	You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

Hospital Pharmacists' Report

December 23, 2010

•	Avastin label change
•	Denosumab improves survival
•	Combination improves tumor RR
•	Denosumab delays side effects
•	Obesity results in higher mortality
•	Herpes simplex combo found safe
•	Few adhere to varenicline
•	New DT Blog

This month we would like to know...

Would you join a pharmacists� union?

• Absolutely not
• Some pharmacists might need one, but I wouldn't join
•I'm afraid to join, in case it jeopardizes my job.
•Sign me up!

Contact Us
Click here to contact a Drug Topics editor.

Click here to contact a Drug Topics sales representative.

Click here to learn about direct mail, reprints and classifieds in Drug Topics.

Drug Topics Digital Edition

Click here to view the current edition.

Click here to subscribe.

FDA begins process to remove breast cancer indication from Avastin label
FDA is recommending removing the breast cancer indication from the label for Avastin (bevacizumab) because the drug has not been shown to be safe and effective for that use. More...

Denosumab improves survival rates in prostate cancer patients
A medication for skeleton-related events in patients with bone metastases was shown to significantly improve bone metastasis-free survival rates in prostate cancer patients, according to a new trial. More...

Combination improves tumor response rates in patients with HER2-positive breast cancers
A combination of lapatinib, trastuzumab, and paclitaxel significantly improved tumor response rates in patients with HER2-positive breast cancers, according to a new study presented at the San Antonio Breast Cancer Symposium held recently in San Antonio, Texas. More...

Denosumab superior to zoledronic acid in delaying first skeletal-related side effect in breast cancer patients
A newly approved drug, denosumab (Xgeva, Amgen), delays skeletal-related side effects for 5 months longer compared to zoledronic acid (Zometa and Reclast, Novartis) in patients with breast cancer and bone metastases, according to phase 3 trial results presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium. More...

Obese women with ER-positive/HER2-negative breast cancer have poorer survival rates
Obesity was associated with worse overall and disease-free survival in women with operable breast cancer treated with adjuvant chemotherapy. More...

No safety issues observed with combination treatment for recurrent herpes simplex labialis
Treatment of recurrent herpes simplex labialis with combination 5% acyclovir and 1% hydrocortisone cream is safe in adolescents. In a study of a 5-day treatment course, no safety concerns were identified, said Anders Strand, MD, PhD, at the 45th midyear meeting of the American Society of Health-System Pharmacists. More...

Patients rarely remain on varenicline in effort to quit smoking
Few patients who are prescribed varenicline to assist in smoking cessation remain on the therapy, according to retrospective data presented during the 45th midyear meeting of the American Society of Health-System Pharmacists. More...

Meetings and events

February 6-8, 2011 NACDS Regional Chain Conference
Naples, FL
Contact:
P.O. Box 34814
Alexandria, VA 22334-0814
703-837-4300

February 13, 2011 19th Annual WILLIAM R. BACON MEMORIAL Breakfast
6:30 a.m. - 8:45 a.m.
Palm Springs, CA
Contact:
800-333-7535; 760-325-6611

March 9-10, 2011 NACDS RxIMPACT Day on Capitol Hill
Washington, DC
Contact:
P.O. Box 34814
Alexandria, VA 22334-0814
[email protected]

March 13-15, 2011 NACDS Supply Chain & Logistics Conference
San Diego, CA
Contact:
P.O. Box 34814
Alexandria, VA 22334-0814
703-683-5678

March 25-28, 2011 American Pharmacists Annual Meeting
Seattle, WA
Contact:
2215 Constitution Avenue, NW
Washington, DC 20037
Phone: 1-800-237-2742 (APhA)
Fax: 202-448-8734

April 30-May 3, 2011 NACDS Annual Meeting
Scottsdale, AZ
Contact:
P.O. Box 34814
Alexandria, VA 22334-0814
703-837-4300

June 25-28, 2011 NACDS Marketplace Conference
Boston, MA
Contact:
P.O. Box 34814
Alexandria, VA 22334-0814
[email protected]

August 27-30, 2011 NACDS Pharmacy & Technology Conference
Boston, MA
Contact:
P.O. Box 34814
Alexandria, VA 22334-0814
703-683-5678

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone
numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other
opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar
Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.